What is the latest AMANTA stock price?
The latest stored price for AMANTA is Rs 172.48 as of 2026-11-03.
gimli
AMANTA stock AI analysis
AMANTA Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
AMANTA HEALTHCARE LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available AMANTA price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹172.48
1W return
+9.34%
1M return
-9.41%
3M return
+0.23%
6M return
+31.53%
1Y return
+42.76%
Market cap
₹669.73 cr
PE
45.62
PB
3.04
ROE
+9.27%
ROCE
+10.92%
RSI
48.20
Turnover
₹2.05 cr
Why it can matter in screens
- Momentum: AMANTA is below 50DMA, above 200DMA; RSI is 48.20.
- Returns: 1D +5.62%, 1W +9.34%, 1M -9.41%, 3M +0.23%, 1Y +42.76%.
- Trend levels: 52W high ₹209.95, 52W low ₹114.05, off high -17.85%.
- Liquidity: latest turnover is ₹2.05 cr; volume vs 20D is +1.07%.
- Valuation/profitability: PE 45.62, PB 3.04, ROE +9.27%, ROCE +10.92%.
- Growth: 3Y sales CAGR +3.76%, 3Y profit CAGR n/a.
Quick Answers
Is AMANTA above its 50DMA and 200DMA?
AMANTA is below 50DMA, above 200DMA. The latest 50DMA is 185.54 and the latest 200DMA is 144.73.
What are AMANTA PE, ROE and ROCE?
AMANTA has PE 45.62, ROE +9.27%, and ROCE +10.92% in Gimli's latest available snapshot.
How has AMANTA performed recently?
AMANTA has returned -9.41% over 1 month, +0.23% over 3 months, and +42.76% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 69.44 cr | 15.19 cr | 3.31 cr | 0.85 |
| 2026-03-31 | 76.99 cr | 16.61 cr | 5.53 cr | 1.61 |
| 2025-12-31 | 74.49 cr | 16.04 cr | 4.63 cr | 1.35 |
| 2025-09-30 | 70.89 cr | 12.09 cr | 1.21 cr | 0.35 |
| 2025-06-30 | 66.27 cr | 15.85 cr | 3.51 cr | 0.90 |
| 2025-03-31 | 72.06 cr | 19.13 cr | 5.96 cr | 1.53 |
| 2024-12-31 | 67.81 cr | 15.93 cr | 4.28 cr | 1.10 |
| 2024-09-30 | 66.73 cr | 14.09 cr | 2.26 cr | 0.58 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 287.68 cr | 60.60 cr | 14.88 cr | 4.33 |
| 2025-03-31 | 274.71 cr | 61.05 cr | 10.50 cr | 2.70 |
| 2024-03-31 | 278.44 cr | 57.52 cr | 3.63 cr | 0.94 |
| 2023-03-31 | 257.53 cr | 55.42 cr | -2.11 cr | -0.54 |
| 2022-03-31 | 226.86 cr | 122.12 cr | 55.11 cr | nan |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 557.98 cr | 81.01 cr | 244.44 cr | 220.21 cr |
| 2025-03-31 | 381.76 cr | 0.22 cr | 192.60 cr | 96.39 cr |
| 2024-03-31 | 352.12 cr | 1.54 cr | 200.08 cr | 66.29 cr |
| 2023-03-31 | 374.06 cr | 0.11 cr | 214.00 cr | 62.88 cr |
| 2022-03-31 | 379.28 cr | 6.38 cr | 213.42 cr | 64.97 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 48.45 cr | -31.74 cr | n/a |
| 2025-03-31 | 46.62 cr | 25.85 cr | n/a |
| 2024-03-31 | 58.07 cr | 44.66 cr | n/a |
| 2023-03-31 | 42.58 cr | 36.29 cr | n/a |
| 2022-03-31 | 63.53 cr | 53.56 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +63.80% | +0.43% | +12.92% | +5.33% | +22.85% | +0.00% |
| 2026-03-31 | +63.72% | +0.85% | +12.88% | +5.09% | +22.56% | +0.00% |
| 2025-12-31 | +63.56% | +1.10% | +11.24% | +3.99% | +24.10% | +0.00% |
| 2025-09-30 | +63.56% | +1.00% | +11.34% | +2.46% | +24.10% | +0.00% |
| 2025-09-08 | +63.56% | +2.21% | +12.22% | +2.46% | +22.02% | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 424,658.30 cr | 35.053345 | +15.50% | +3.72% |
| DIVISLAB | DIVI S LABORATORIES LTD | 267,167.60 cr | 91.684145 | +18.37% | +47.91% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 157,377.11 cr | 74.094685 | +16.87% | +28.16% |
| LAURUSLABS | LAURUS LABS LIMITED | 125,408.69 cr | 114.827348 | +21.77% | +138.16% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 124,833.39 cr | 27.818646 | +16.04% | +26.46% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 121,354.29 cr | 57.614911 | +22.62% | +7.87% |
| DRREDDY | DR. REDDY S LABORATORIES | 113,923.95 cr | 40.698752 | +7.80% | +14.41% |
| CIPLA | CIPLA LTD | 112,841.65 cr | 38.950805 | +8.80% | -7.58% |
Try these prompts
- Analyze AMANTA HEALTHCARE with valuation, momentum and industry peers
- Compare AMANTA with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare AMANTA with other Healthcare stocks
Data snapshot: 2026-11-03. Not investment advice.